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expression of the analyzed genes with comparable results in all 
experiments in a concentration dependent fashion. Results from 
a representative xperiment are reported in the table and are ex- 
pressed as % inhibition vs IL-11~ stimulation. 
% inhibition 
IL-lb 2 ng/ml IL-lb 10 ng/ml 
NFkB1 GS 0,1 mM -23 -40 
GS 10 mM -115 -85 
NFkB2 GS 0,1 mM -36 -62 
GS 10 mM -104 -102 
Rel A GS 0,1 mM -15 -42 
GS 10 mM -94 -106 
Rel B GS 0,1 mM -32 -54 
GS 10 mM -85 -92 
Jun B GS 0,1 mM -39 -25 
GS 10 mM -76 -70 
EGR-1 GS 0,1 mM -20 -11 
GS 10 mM -73 -89 
Conclusions: In a human chondrocyte-like cell model, therapeu- 
tically relevant concentrations of GS inhibited IL-11~-stimulated 
expression of early response genes including NFkB and AP-1 
family members, and EGR-1. Since these transcription factors in 
turn regulate the expression of several pro-inflammatory and pro- 
degenerative genes, GS favorable effects in this respect might 
be initiated by the previously reported inhibition of transcription 
factors activation and sustained thereafter by the presently de- 
scribed inhibition of their expression. In addition, the decrease 
in EGR-1 overexpression may limit cytokine-induced cell growth 
dysregulation. 
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Aim: To determine the effects of selenomethionine and epigallo- 
catechin gallate on gene expression, activation of mitogen acti- 
vating kinases and DNA-binding of NF-KB and AP-1 in articular 
chondrocytes. 
Methods: Chondrocytes, cultured in low-oxygen tension, were 
pre-treated with L-selenomethionine or EGCg for 24 h, followed 
by IL-11~ for further 1 h (nuclear and cytoplasmic extracts) or 24 
h (RNA extraction). RT-PCR was performed to determine mRNA 
levels of MMPs (-1, -3, -13), aggrecanases (-1, -2), interleukin-11~, 
inducible nitric oxide synthase, cyclooxygenases (-1, -2), type II 
collagen and aggrecan, transforming growth factor-I~ (-1, -2, -3) 
and their receptors I and II. Activity of mitogen-activating protein 
kinases was assayed by Western-blotting and AP-1/NF-KB DNA- 
binding by electrophoretic mobility shift assay. 
Results: Pre-treatment with 0.5 I~M Se-met prevented IL-11~- 
induced MMP-1 and aggrecanase-1 expression, and reduced the 
cytokine inhibitory effect of on type II collagen, aggrecan core pro- 
tein, and TI~RII mRNA levels. EGCg was more efficient in modu- 
lating the IL-11~ effects on the genes studied. Whereas EGCg in- 
hibited the IL-11~-activated MAPK, NF-KB and AP-1, Se-met stim- 
ulated that signaling pathway. This could account for the differen- 
tial effects exerted by these antioxidants on chondrocytes. 
Conclusions: The data provide insights into the mechanisms 
whereby epigallocatechin gallate and selenium modulate chon- 
drocyte metabolism. Despite their differential mechanisms of ac- 
tion, the two compounds could exert global beneficial effect on 
articular cartilage. 
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Aim: To determine the effect of pharmacologically relevant con- 
centrations of rhein, the metabolite of diacerhein, on signaling 
pathways and expression of genes related to catabolism or an- 
abolism of extracellular matrix of bovine articular chondrocytes 
cultured in low oxygen tension and exposed to interleukin-1 (IL- 
l). 
Methods: Bovine articular chondrocytes were isolated by en- 
zymatic procedure and cultured as monolayers in DMEM+10% 
FCS, either at normal atmosphere (21% 02) or in hypoxia (3% 
02). They were treated or not with IL-11~ (10 ng/ml) and rhein (10- 
4-10-5M, Negma Laboratories, Paris). At the end of experiments, 
cytoplasmic extracts were prepared and used in Western-blotting 
to detect ERK1/2, Jun and p38 kinases. Nuclear proteins were 
also extracted and subjected to EMSA analysis of NF-KB and AP- 
1 DNA binding. Total RNA was isolated and reverse transcribed to 
cDNA, which was then subjected to the relative quantitative real- 
time PCR (Q-RT-PCR) procedure, using the ABI PRISM 7000 and 
SYBR green detection and specific primers for type II collagen, 
aggrecan core protein, MMP-1, -3, -13, aggrecanases 1 and 2. 
RT-PCR data were normalized with 18S RNA and gene expres- 
sion relative to control was calculated with the delta delta cycle to 
threshold (ddCt) method. 
Results: Chondrocytes in hypoxia respond to I L-11~ (10 ng/ml) 
by an increased DNA binding activity of NF-KB and AP-1 tran- 
scription factors. Incubation with 10-5 M rhein for 24 h was found 
to reduce this activity. IL-11~-induced ERK-1 and ERK-2 activity 
was greater in hypoxia than in normoxia. Rhein was capable of 
reducing this effect, whatever the oxygen level. In contrast, no 
significant effect of the drug on the activity of p38 kinase was ob- 
served. Rhein was also found to decrease the IL-1 induced Jun 
kinase activation. 
The mRNA levels of type II collagen and aggrecan core protein 
were increased by a 24-h treatment with 10-5 M rhein. This ef- 
fect was also observed in the presence of IL-11~, indicating that 
the drug could prevent or reduce the IL-11~-induced inhibition of 
matrix synthesis. IL-1-induced expression of most degrading en- 
zymes (MMP-1, -3, -13, aggrecanase 1 ) was significantly reduced 
by rhein in the same conditions, except for aggrecanase 2. 
Conclusions: Rhein can inhibit the IL-l-activated MAPK path- 
way and the DNA binding of NF-KB and AP-1, two key factors 
involved in the expression of several pro-inflammatory genes by 
chondrocytes. The drug also reduces the procatabolic effect of 
the cytokine, by reducing the synthesis of most degrading en- 
zymes, and enhances the synthesis of cartilage specific compo- 
nents, such as type II collagen and aggrecan. These effects may 
explain the anti-osteoarthritic properties of rhein and its disease- 
modifying effects on OA cartilage. 
